Non-coronary arterial disease: Of intercot to cardiologists?;Patología arterial no coronaria: ¿de interés para el cardiólogo?

Revista Espanola de Cardiologia

Volumn 60, Issue 2, 2007, Pages 179-183

  Alfonso, Fernando ^a   Segovia, Javier ^a   Heras, Magda ^a   Bermejo, Javier ^a  

^a Nuestra Senora de Guadalupe   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; AORTA ARCH SYNDROME; AORTA DISEASE; ARTICLE; ATHEROSCLEROSIS; CARDIOLOGY; CAROTID ARTERY DISEASE; CAROTID ARTERY SURGERY; CEREBROVASCULAR DISEASE; EVIDENCE BASED MEDICINE; HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RENOVASCULAR DISEASE; STENT; FEMALE; KIDNEY ARTERY STENOSIS; MALE; SPAIN;

AORTIC ANEURYSM, ABDOMINAL; ATHEROSCLEROSIS; CARDIOLOGY; CAROTID ARTERY DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; RENAL ARTERY OBSTRUCTION; SPAIN;

EID: 33947572556     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13099464     Document Type: Article

References (35)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-26.
2. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (Lower extremity, renal, mesenteric and abdominal aortic). A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascualr Medicine and Biology, Society of Interventional radiology and the ACC/ AHA Tasck Force on Practice Guidelines. Circulation. 2006; 113:e463-e654.
3. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus. J Vasc Surg. 2000;31:S1-296.
4. Alegría E, Cordero A, Laclaustra M, Grima A, Leon M, Casasnovas JA, et al. Investigadores del registro MESYAS. Prevalencia del síndrome metabólico en población laboral española: registro MESYAS. Rev Esp Cardiol. 2005;58:797-806.
5. Sánchez-Chaparro MA, Román-García J, Calvo-Bonacho E, Gómez-Larios T, Fernández-Meseguer A, Sainz-Gutiérrez JC, et al. Prevalencia de factores de riesgo vascular en la población laboral española. Rev Esp Cardiol. 2006;59:421-30.
6. Marrugat J, Solanas P, D'Agostino R, Sullivan L, Ordovas J, Cordon F, et al. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253-61.
7. Agatston AS, Janowitz WR, Hildner FJ, Zusner NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultra-fast computed tomography. J Am Coll Cardiol. 1990;15:827-32.
8. Achenbach S, Moselewski F, Ropers D, Ferencick M, Hoffman U, MacNeill B, et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation. 2004; 109:14-7.
9. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution non-invasive magnetic resonance imaging. Circulation. 2002; 106:2884-87.
10. Medrano MJ, Boix R, Cerrato E, Ramírez M. Incidence and prevalence of ischemic heart disease and cerebrovascular disease in Spain. A systematic review of the literature. Rev Esp Salud Publica. 2006;80:5-15.
11. Truelsen T, Piechowski B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol. 2006;13:581-98.
12. Abadal LT, Puig T, Balaguer Vintro I. Accidente vascular cerebral. Incidencia, mortalidad y factores de riesgo en 28 años de seguimiento. Rev Esp Cardiol. 2000;53:15-20.
13. Marrugat J, Arboix A, García-Eroles L, Salas T, Vila J, Castell C, et al. Estimación de la incidencia poblacional y letalidad de la enfermedad vascular cerebral establecida isquémica y hemorrágica en 2002. Rev Esp Cardiol 2006. En prensa.
14. Izumihara A, Suzuki M, Ishihara T. Recurrence and extension of lobar hemorrhage related to cerebral amyloid angiopathy: multivariate analysis of clinical risk factors. Surg Neurol. 2005; 64:160-4.
15. Centro Nacional de Epidemiología. Enfermedades cerebrovasculares. Disponible en: 193.146.50.130/raziel/maps/fmap.php.
16. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-59.
17. Kent DM. Stroke-An equal opportunity for the initiation of statin therapy. N Engl J Med. 2006;355:613-15.
18. Cambria RP. Stenting for carotid-artery stenosis. N Engl J Med. 2004;351:1565-7.
19. Chatuverdi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, et al. Carotid endarterectomy: an evidence review. Report of the Therapeutics and technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2005;65;794-801.
20. Yadav JS, Wholey MH, Kuntz RE. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-501.
21. Coward LJ, Featherstone RL, Brown MM. Safety and efficacy of endovascular treatment of carotid stenosis compared with carotid endarterectomy: a Cochrane systematic review of randomised evidence. Stroke. 2005;36:905-11.
22. The SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006;368:1239-47.
23. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006; 355:1660-71.
24. Biasi GM, Froio A, Diethrich EB, Deleo G, Galimberti S, Mingazzini P et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting. The imaging in carotid angioplasty and risk of stroke (ICAROS) study. Circulation. 2004; 110;756-62.
25. Huelmos A, Jiménez J, Guijarro C, Belinchon JC, Puras E, Sánchez C, et al. Enfermedad arterial periférica desconocida en pacientes con síndrome coronario agudo: prevalencia y patrón diferencial de los factores de riesgo cardiovascular tradicionales y emergentes. Rev Esp Cardiol. 2005; 58:1403-10.
26. Lahoz C, Mostaza JM. Índice tobillo-brazo: una herramienta útil para la estratificación del riesgo cardiovascular. Rev Esp Cardiol. 2006;59:647-9.
27. Erbel R, Alfonso F, Boileau C, Dirsch O, Eber B, Haverich A, et al. Diagnosis and management of aortic dissection. Eur Heart J. 2001;22:1642-81.
28. Martín M, Moils C, Lozano I, Llaneza JM, Vega F, Fernández F, et al. Tratamiento percutáneo de las afecciones de la aorta torácica. Una labor multidisciplinaria. Rev Esp Cardiol. 2005;58: 27-33.
29. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. An Intern Med. 2005; 142: 198-202.
30. Prinssen M, Verhoeven ELG, Buth J. A randomized trial comparing convencional and endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2004;351:1607-18.
31. Blankensteijn JD, De Jong SE, Prinssen M, Van der Ham AC, Buth J, Sterkenburg SM, et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2005;352;2398-405.
32. McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, et al. Coronary artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-804.
33. Lederle FA. Endovascular repair of abdominal aortic aneurysm: round two. N Engl J Med. 2005;352:2443-5.
34. Alfonso F, Bermejo J, Segovia J. Estado actual de la revascularización coronada. Rev Esp Cardiol. 2005;58:194-7.
35. Alfonso F, Bermejo J, Segovia J. Enfermedades cardiovasculares en la mujer: ¿por qué ahora? Rev Esp Cardiol. 2006;59: 259-63.